Company: MDCXW
Filing Date: 2025-09-11
Form Type: DRS
Source: 0001062993-25-015568
Chunk: 193

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-11
Form: DRS
Chunk 193
---
,250 (11 | ) |     | *             |
| Barry Fishman                                                               |     |    46,250 (12 | ) |     | *             |
| Sara R. May                                                                 |     |    46,250 (13 | ) |     | *             |
| Hon. Cathy McMorris Rodgers                                                 |     |             - |   |     | *             |
| Patrick J. Mahaffy                                                          |     |        35,435 |   |     | *             |
| All officers and directors as a group (14 individuals)                      |     |     4,293,824 |   |     | 20.2%         |
| Five Percent Holders of Medicus Pharma Ltd. (other than those listed above) |     |               |   |     |               |
| Dr. Kenneth Melani                                                          |     | 3,248,741 (14 | ) |     | 16.1%         |

* Less than one percent.

(1)Unless otherwise noted, the business address of each of our directors and executive officers is 300 Conshohocken State Rd., Suite 200, W. Conshohocken, PA 19428.

<div align='center'>130</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

(2)Includes 793,173 common shares held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. Dr. Raza Bokhari may be deemed the beneficial owner of securities held by RBx Capital, LP. Includes 362,500 common shares underlying stock options that are currently exercisable.

(3)Includes 12,500 common shares underlying stock options and 24,000 common shares underlying Public Warrants that are currently exercisable or will become exercisable.

(4)Includes 85,000 common shares underlying stock options that are currently exercisable.

(5)Includes 107,500 common shares underlying stock options and 24,000 common shares underlying Public Warrants that are currently exercisable.

(6)Includes 112,500 common shares underlying stock options that are currently exercisable.

(7) Includes 100,000 common shares underlying stock options that are currently exercisable.

(8) Includes 2,000,000 common shares held of record by 215 Capital Togo PHL Fund I